069620 — Daewoong Pharma Share News
0.000.00%
Last trade - 00:00- KR₩1tn
- KR₩2tn
- KR₩2tn
S.Korea's Daewoong Pharma gets approval for Phase 1 trials of COVID-19 anti-parasite drug
Brief: Daewoong Pharmaceutical Welcomes ITC Decision to Review Judge’s Initial Determination
S.Korea's Daewoong Pharma gets India nod to test anti-parasite drug for COVID-19
Brief: Evolus Says Daewoong Pharmaceutical to invest $40 Million in Co
S.Korea's Daewoong Pharmaceutical says anti-parasitic drug effective against coronavirus in animal tests
Brief: Daewoong Pharmaceutical Unveils Phase 3 Clinical Data Of Fexuprazan, A Novel Potassium-Competitive Acid Blocker
Rises on agreement with AffyXell Therapeutics
Director Appointment
Brief: Avacta And Daewoong Establish Joint Venture
Brief: Daewoong Acquires Shares Worth 5 Billion Won In Daewoong Pharma
Brief: Daewoong Pharma Says Signs $12 Mln Worth Deals In New Zealand, Israel, Ukraine
Media: Daewoong Pharmaceutical to export botox to New Zealand, Israel, Ukraine - Yonhap
Brief: Daewoong Pharma to pay annual cash dividend as 600 won/share
Brief: Daewoong Pharma to pay annual dividend as 600 won/share for FY 2016
Brief: Daewoong Pharma signs contract worth 72.8 bln won
Seoul shares track Wall St. higher, foreign net-selling persists
Seoul shares track Wall St. higher, foreign net-selling persists
Seoul shares track Wall St. higher, foreign net-selling persists